Diagnostic significance of antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary oral hypoglycemie agents failure

Clinical Immunology and Immunopathology

Volumn 85, Issue 2, 1997, Pages 182-186

  Fukui, Michiaki ^a   Nakano, Koji ^a   Maruya, Etsuko ^a   Saji, Hiroh ^a   Ohta, Kiyoe ^a   Ohta, Mitsuhiro ^a   Obayashi, Hiroshi ^a   Mori, Hiroshi ^b   Kajiyama, Shizuo ^c   Wada, Shigeo ^a   Shigeta, Hirofumi ^d   Kitagawa, Yoshihiro ^a   Nakamura, Naoto ^a   Kondo, Motoharu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b JAPANESE RED CROSS SOCIETY   (Japan)

^c UTANO NATIONAL HOSPITAL   (Japan)

^d KYOTO CITY HOSPITAL   (Japan)

Author keywords

Antibodies to glutamic acid decarboxylase; HLA DRB1; Non insulin dependent diabetes mellitus; Secondary oral hypoglycemie agents failure

Indexed keywords

ANTIDIABETIC AGENT; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DR ANTIGEN; SULFONYLUREA; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; GENETIC MARKER; HUMAN; HUMAN CELL; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PREVALENCE; PRIORITY JOURNAL;

EID: 0030730155     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4442     Document Type: Article

References (25)

1. Rowley, M. J., Mackay, I. R., Chen, Q., Knowles, W. J., and Zimmet, P. Z., Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 41, 548-551, 1992.
2. Hagopian, W. A., Karlsen, A. E., Gottsater, A., et al., Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J. Clin. Invest. 91, 368-374, 1993.
3. Zimmet, P. Z., Tuomi, T., Mackay, I. R., et al., Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetic Med. 11, 299-303, 1993.
4. Tuomilehto, J., Zimmet, P., Mackay, R., et al., Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343, 1383-1385, 1994.
5. Tuomi, T., Groop, L. C., Zimmet, P. Z., Rowley, M. J., Knowles, W., and Mackay, I. R., Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a noninsulin-dependent onset of disease. Diabetes 42,359-362,1993.
6. - 6. Niskanen, L. K, Groop, L. C., Tuomi, T., et al, GAD antibodies in NIDDM: Ten-year follow-up from the diagnosis. Diabetes Care 18, 1557-1565, 1995.
7. r autoantibodies as predictors of insulindependent diabetes. Lancet 335, 1357-1360, 1990.
8. Fukui, M., Nakano, K., Shigeta, H., et al., Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapy. Diabetic Med. 14, 148-152, 1997.
9. Pittman, W. B., Acton, R. T., Barger, B. O., et al, HLA-A, -B, and -DR associations in type l diabetes mellitus with onset after age forty. Diabetes 31, 122-125, 1982.
10. Groop, L., Groop, P. H., and Koskimies, S., Relationship between B-cell function and HLA antigens in patients with Type 2 (noninsulin-dependent) diabetes. Diabetologia 29, 757-760, 1986.
11. Groop, L., Miettinen, A., Groop, P. H., Men, S., Koskimies, S., and Bottazzo, G. F., Organ-specific autoimmunity and HLA-DR antigens as markers for β-cell destruction in patients with type 2 diabetes. Diabetes 37, 99-103, 1988.
12. Ludvigsson, J., Samuelsson, U., Beauforts, C., et al., HLA-DR3 is associated with a more slowly progressive form of Type 1 (insulin-dependent) diabetes. Diabetologia 29, 207-210, 1986.
13. National Diabetes Data Group, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28, 1039-1057, 1979.
14. Ohta, M., Obayashi, H., Takahashi, K., et al., A simple solid-. phase radioimmunoassay for glutamic acid decarboxylase (GAD) antibodies in patients with diabetes mellitus. J. Clin. Biochem. Nutr. 20, 139-148, 1996.
15. Maruya, E., Saji, H., and Yokoyama, S., PCR-LIS-SSCP (low ionic strength single-stranded conformation polymorphism)-A simple method for high-resolition allele typing of HLA-DRB1, -DQB1, and -DPB1. Genome Res. 6, 51-57, 1996.
16. Awata, T., and Kanazawa, Y.( Genetic markers for insulin-dependent diabetes mellitus in Japanese. Diabetes Res. Clin. Pract. 24(Suppl.), 83-87, 1994.
17. Karvonen, M., Tuomilehto, J., Libman, I., and LaPorte, R., for the World Health Organization DIAMOND Project Group, A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36, 883-892, 1993.
18. Serjeantson, S. W., Kohonen-Corish, M. R. J., Rowley, M. J., Mackay, I. R., Knowles, W., and Zimmet, P., Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35, 996-1001, 1992.
19. Tuomi, T., Zimmet, P., Rowley, M. J., et al., Differing frequency of autoantibodies to glutamic acid decarboxylase among Koreans, Thais, and Australians with diabetes mellitus. Clin. Immunol. Immunopathol. 74, 202-206, 1995.
20. Awata, T., Kuzuya, T., Matsuba, A., Iwamoto, Y., and Kanazawa, Y., Genetic analysis of HLA class 2 alleles and susceptibility to Type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 35, 419-424, 1992.
21. Zucman, S. C., Garchon, H. J., Timsit, J., et al., Age-dependent HLA genetic heterogeneity of Type 1 insulin-dependent diabetes mellitus. J. Clin. Invest. 90, 2242-2250, 1992.
22. Mimura, G., Kida, K., and Murakami, K, A multicenter study on HLA and autoimmunity in Japanese patients with early-onset insulin-dependent diabetes mellitus (IDDM): The JDS study. Diabetes Res. Clin. Pract. S24, S75-S81, 1994.
23. Abiru, N., Takino, H., Yano, M., et al., Clinical evaluation of noninsulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase. J. Autoimmun. 9, 683-688, 1996.
24. Elliott, R. B., and Chase, H. P., Prevention or delay of Type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia 34, 362-365, 1991.
25. Keller, R. J., Eisenbarth, G. S., and Jackson, R. A., Insulin prophylaxis in individuals at high risk of type 1 diabetes. Lancet 341, 927-928, 1993.